Third Rock Ventures logo

Third Rock Ventures

North America, Massachusetts, United States, Boston

Description

Third Rock Ventures invests in transformational life science companies that show high growth potential.

Investor Profile

Third Rock Ventures has made 141 investments, with 7 in the past 12 months and 45% as lead.

Stage Focus

  • Series A (45%)
  • Series B (31%)
  • Series C (11%)
  • Series D (3%)
  • Series Unknown (3%)
  • Seed (2%)
  • Private Equity (2%)
  • Series E (1%)
  • Series F (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Genetics
  • Medical Device
  • Biopharma
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Third Rock Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 10
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 11
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 12
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 16
Casdin Capital
North America, New York, United States, New York
Co-Investments: 26
The Column Group
North America, California, United States, San Francisco
Co-Investments: 18
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 10
Invus
North America, New York, United States, New York
Co-Investments: 13
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 14
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 9

Which angels does Third Rock Ventures often collaborate with?

BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
VW
North America, Florida, United States, Miami Beach
Shared Deals: 1
Dan Burgess
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Third Rock Ventures?

Trace Neuroscience

South San Francisco, California, United States

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

BiotechnologyHealth CareLife Science
Series ANov 12, 2024
Amount Raised: $101,000,000
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 21, 2024
Amount Raised: $225,000,000
Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Marea Therapeutics

San Francisco, California, United States

Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.

BiotechnologyGeneticsLife Science
Series BJun 18, 2024
Amount Raised: $190,000,000
Marea Therapeutics

San Francisco, California, United States

Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.

BiotechnologyGeneticsLife Science
Series AJun 18, 2024
Amount Raised: $65,418,629
CARGO Therapeutics

San Mateo, California, United States

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMay 28, 2024
Amount Raised: $110,000,000
Asher Bio

San Francisco, California, United States

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

BiotechnologyTherapeutics
Series CApr 16, 2024
Amount Raised: $55,000,000
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceutical
Series AApr 9, 2024
Amount Raised: $100,000,000
Clasp Therapeutics

Cambridge, Massachusetts, United States

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

BiotechnologyTherapeutics
Series AMar 20, 2024
Amount Raised: $150,000,000
Synnovation Therapeutics

Wilmington, Delaware, United States

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series ADec 14, 2023
Amount Raised: $102,000,000